This conversation guide provides information for community-based organizations, TB programs, and healthcare providers to talk with their clients about the TB screening and attestation requirements of the Uniting for Ukraine program.
This conversation guide provides information for community-based organizations, TB programs, and healthcare providers to talk with their clients about the TB screening and attestation requirements of the Uniting for Ukraine program.
The Population Assessment of Tobacco and Health (PATH) Study provides the scientific community with biospecimens (urine, plasma, serum, and genomic DNA) and related research data on behaviors, attitudes, biomarkers and health outcomes associated with tobacco use in the U.S. This opportunity allows investigators to apply for access to the biospecimens from the PATH Study.
The purpose of this Notice of Funding Opportunity (NOFO) is to support the development of a comprehensive and well-defined product development strategy for next-generation treatments for HIV and HIV-associated comorbidities, coinfections and complication and preventive strategies for HIV, as well as facilitating the translation of research findings into drug products that enables submission of an Investigational New Drug (IND) application to the FDA.
This NOSI aims to stimulate advances in diagnosis and treatment of NTM infections that cause or exacerbate pulmonary disease such as Mycobacterium abscessus, Mycobacterium avium complex, and Mycobacterium kansasii. Areas of interest include but are not limited to:
May is Hepatitis Awareness Month (HAM) and May 19th is Hepatitis Testing Day. Use the following social media toolkit to amplify hepatitis awareness!
An infographic from HepVu on Hepatitis A.
An infographic from HepVu on Hepatitis B.
An infographic from HepVu on Hepatitis C.
The FOA seeks to expand the HIV/AIDS prevention toolkit among alcohol impacted populations with a range of patterns of episodic and long-term use and associated behavioral and biological risks for HIV acquisition. This includes integration of effective prevention and treatment interventions with an understanding of the overarching framework for reducing the incidence of new infections by facilitating cross-cutting informative research.
